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Melimine and Mel4 are chimeric cationic peptides with broad-spectrum antimicrobial activity. They 
have been shown to be highly biocompatible in animal models and human clinical trials. The current 
study examined the mechanism of action of these two antimicrobial peptides against P. aeruginosa. the 
effect of the peptides of endotoxin neutralization, and their interactions with cytoplasmic membranes 
using DiSC(3)-5 and Sytox green, Syto-9 and PI dyes were analysed. Release of ATP and DNA/RNA were 
determined using ATP luminescence and increase in OD260 nm. The bacteriolytic ability of the peptides 
was determined by measuring decreases in OD620 nm. Both the peptides neutralized LPS suggesting 
their interaction with lipid A. Cytoplasmic membrane was disrupted within 30 seconds, which correlated 
with reductions in cellular viability. At 2 minutes melimine or Mel4, released 75% and 36% cellular ATP 
respectively (P < 0.001). Membrane permeabilization started 5 minutes with simultaneous release of 
DNA/RNA. Flow cytometry demonstrated 52% and 18% bacteria were stained with PI after 30 minutes. 
Overall, melimine showed higher capacity for membrane disruption compared to Mel4 (P < 0.001). The 
findings of this study have been summarized as a timeline of bactericidal activity, suggesting that the 
peptides permeabilized P. aeruginosa within 5 minutes, started lysis within 2 hours of exposure.
Pseudomonas aeruginosa is a metabolically versatile ubiquitous Gram-negative opportunistic pathogen that 
can cause infections in animals and plants1. P. aeruginosa is responsible for localized and systemic infections 
in humans, which can be life threatening. P. aeruginosa has become one of the most frequent causative agents 
of nosocomial infections associated with substantial morbidity and mortality2. The current standards of care to 
treat P. aeruginosa infections are not effective3 as its outer membrane offers low permeability to some antibiotics 
resulting in antibiotic resistance4,5. Given the severity of P. aeruginosa infections and the limited antimicrobial 
arsenal with which to treat them, finding new alternative antimicrobials with unique mechanisms of action is 
urgently required6.
Antimicrobial peptides (AMPs) are part of the innate immune response of living organisms and have broad 
spectrum activity ranging from viruses to parasites at low concentrations7. AMPs are usually cationic in nature 
and have a varying number (from five to over a hundred) of amino acids. AMPs possess multiple modes of action, 
rapid bacterial killing kinetics and can be constructed to have little toxicity toward human cells8,9. Bacteria do not 
easily gain resistance to AMPs due to their fast killing mechanism and multiple target sites10,11. The mechanism of 
action of AMPs starts by interacting with negatively charged lipopolysaccharides (LPS) in the outer membranes 
of Gram-negative bacteria12–14 leading to a destabilization and permeabilization15. AMPs are then able to interact 
with the cytoplasmic membrane. Several models for the interaction of AMPs with bacterial cytoplasmic mem-
branes have been proposed, such as “barrel stave”, “toroidal pore” and “carpet model”12. In all of these models 
AMPs displace lipids, alter membrane structure and these interactions result in leakage of cellular contents such 
as K+, ATP and DNA/RNA, resulting in cell death16,17. Some AMPs can also act intracellularly disrupting DNA, 
RNA and protein synthesis18,19.
Melimine (TLISWIKNKRKQRPRVSRRRRRRGGRRRR) is a cationic hybrid peptide of melittin and pro-
tamine20. It has broad spectrum activity against a wide range of Gram-negative and Gram-positive bacteria 
(including MRSA and multi drug resistant P. aeruginosa), fungi and the protozoan such as Acanthamoeba20,21. 
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Importantly, bacteria did not develop resistance against melimine when exposed at sub-MIC for 30 consecu-
tive days20. Moreover, melimine is not cytotoxic at well above active concentrations20,21. Melimine has a random 
coil confirmation in aqueous environments but increases its α-helical content (to 40%) in bacterial membrane 
mimetic environments. This change in conformation upon binding to the membrane is widely accepted as the 
first step in the mechanism of action of many AMPs22. Melimine disrupts the outer membrane and rapidly 
destroys the inner membrane potential of P. aeruginosa23. Melimine retains its antimicrobial activity when bound 
to polymers and titanium20,21,24.
A shorter sequence of melimine called Mel4 (KNKRKRRRRRRGGRRRR) has been designed which was 
shown to have improved ocular compatibility when bound to contact lenses25. Mel4 is highly active against 
P. aeruginosa in solution or when immobilized on surfaces26. It is noncytotoxic to mammalian cells in vitro20,21, in 
animal model studies and in human clinical trials25,27. Mel4 has had several amino acids removed from melimine’s 
sequence, including the single tryptophan in melimine. Tryptophan is known to be a highly lipophilic amino acid28, 
and many cationic peptides contain tryptophan as an important part of their mode of action29–31. Similarly, other 
non-polar amino acids such as Leu and Ile can encourage peptide binding and disruption of cell membranes32. 
Although Mel4 have been extensively investigated with human clinical trials, its bactericidal mechanism 
is unknown. Hence, this study examined and compared the mode of action of melimine and Mel4 against 
P. aeruginosa.
Results
Inhibitory concentrations of peptides. MICs and MBCs for melimine and Mel4 against P. aeruginosa are 
shown in Table 1. Mel4 had a low MIC of 26.6 nmol/ml against P. aeruginosa strains 6294, 6206 and ATCC 19660. 
Melimine had its lowest MIC 66 nmol/ml against 6294, 6206 and Paer1. For all strains the MBC was usually 2x 
the MIC except for strain 6294 where the MBC for both melimine and Mel4 was ≥4x the MIC while for ATCC 
19660 the MBC for Mel4 was equivalent to the MIC. Melimine at its lowest MBC needed 1.59 × 1012 molecules 
per cell to cause death whereas Mel4 needed 3.2 × 1011 molecules per cell to cause cell death at its lowest MBC.
Interaction with Lipopolysaccharides. The LAL test was used to assess the ability of the AMPs to inter-
act and neutralize the LPS. Both melimine and Mel4 inhibited LPS’s ability to stimulate amoebocyte lysate in a 
dose-dependent manner as demonstrated in Table 3. At 1x MIC, melimine significantly neutralized LPS and 
reduced OD405 nm by 71% compared to the positive control (P < 0.001). At 2x MIC melimine neutralized approx-
imately 82% LPS (Table 2). Compared with melimine, less neutralization of LPS activity in the LAL assay was 
achieved with Mel4 while decreasing the OD405 nm by 47% at 1x MIC and 62% at 2x MIC (P < 0.001). None of the 
tested peptides induced Limulus proenzyme activation when incubated in the absence of LPS.
Membrane disruption. Both melimine and Mel4 rapidly within 30 seconds depolarized the cytoplasmic 
membrane of P. aeruginosa in a concentration dependent manner. Figure 1A shows the data for P. aeruginosa 
Bacterial strains
Melimine Mel4
MIC nmolml−1 
(µgml−1)
MBC nmolml−1 
(µgml−1)
MIC nmolml−1 
(µgml−1)
MBC nmolml−1 
(µgml−1)
P. aeruginosa 6206 66 (250) 132 (500) 26.6 (62.5) 53.2 (125)
P. aeruginosa 6294 66 (250) 528 (2000) 26.6 (62.5) 106.5 (250)
P. aeruginosa Paer1 66 (250) 132 (500) 106.5 (250) 213 (500)
P. aeruginosa ATCC 19660 132 (500) 264 (1000) 26.6 (62.5) 26.2 (62.5)
Table 1. MIC and MBC values of melimine and Mel4 against strains of P. aeruginosa. MIC = minimum 
inhibitory concentration that inhibits the growth of ≥90% of cells. MBC = minimum bactericidal concentration 
that kills ≥99.9% of cells.
Experimental conditions
Optical Density at 405 nm (% reduction 
compared to positive control)*
Positive control: LPS + LAL reagent 2.47 ± 0.25 (0%)
Negative control: LPS + Endotoxin free Water 0.29 ± 0.08 (88.4 ± 3.6%)
Test: Melimine (1x MIC) + LPS + LAL Reagent 0.76 ± 0.13 (70.6 ± 5.6%)
Peptide control: Melimine (1x MIC) + LAL Reagent 0.47 ± 0.07 (81 ± 2.6%)
Test: Melimine (2x MIC) + LPS + LAL Reagent 0.46 ± 0.06 (81.5 ± 3.1%)
Peptide control: Melimine (2x MIC) + LAL Reagent 0.43 ± 0.10 (82.1 ± 6.1%)
Test: Mel4 (1x MIC) + LPS + LAL Reagent 1.30 ± 0.10 (46.7 ± 9.7%)
Peptide control: Mel4 (1x MIC) + LAL Reagent 0.73 ± 0.15 (70.5 ± 3.3%)
Test: Mel4 (2x MIC) + LPS + LAL Reagent 0.93 ± 0.21 (61.9 ± 9.0%)
Peptide control: Mel4 (2x MIC) + LAL Reagent 0.87 ± 0.23 (62.3 ± 13.4%)
Table 2. Percentage reduction in OD405 nm. LPS = lipopolysaccharide; LAL = Limulus amoebocyte lysate; 
MIC = minimum inhibitory concentration; *All reductions in LAL activity were significantly different 
compared to the positive control (P ≤ 0.05).
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6294, whereas data for all other strains are available in the Supplementary Information. Following 150 seconds of 
exposure, no further depolarisation (increase in the release of DiSC3-(5)) occurred for any of the strains. More 
depolarisation occurred with the higher median MIC of melimine (66 nmol/ml) compared to the median MIC 
of Mel4 (26.6 nmol/ml), and the same trend was observed throughout the time course (P < 0.005). This depo-
larization of the cytoplasmic membrane was associated with >3.6 log10 reduction in colony forming units of P. 
aeruginosa 6294 for melimine at its MIC (66 nmol/ml) or MBC (132 nmol/ml). Similarly, there was >2.7 log10 
reduction in bacterial numbers by Mel4 at its MIC (26.6 nmol/ml) and MBC (53.2 nmol/ml) (Fig. 1B). The control 
substance sodium azide also depolarized the cell membrane and released DiSC3-(5) but without bacterial killing.
Sytox green fluorescence, a measure of permeabilization of the cytoplasmic membrane, increased over 
time and its release was significantly different to the negative control after 5 minutes incubation with both 
AMPs(P < 0.005) (Fig. 2). The permeabilization gradually increased over 30 minutes for all the peptide concen-
trations for all strains. However, this effect was not concentration dependent for either peptide as no signifi-
cant differences were observed between the MIC and MBC. At their respective MICs, melimine allowed more 
Sytox green to enter cells than Mel4 after 150 mins (P < 0.001). Treatment with the positive control Triton-X 100 
resulted maximum membrane permeabilization.
Peptides
Molecular 
mass
Number of 
amino acids
Net 
charge
Hydro-phobicity 
<H>*
Hydrophobic 
moment <µH>*
Polar residue 
(number)
Non-polar residue 
(number)
Melimine 3786.6 29 +16 −0.250 0.222 23 6
Mel4 2347.8 17 +14 −0.846 0.039 17 0
Table 3. Properties of melimine and Mel4 peptides. *The properties were predicted using online software http://
heliquest.ipmc.cnrs.fr/cgi-bin/ComputParams.py.
Figure 1. Cytoplasmic membrane depolarization of P. aeruginosa 6294 by melimine and Mel4, as assessed 
by release of the membrane potential-sensitive dye DiSC3-(5) measured spectroscopically at 622 nm to 670 nm 
excitation and emission wavelength, and corresponding bacterial survival as determined by plate counts. Data 
presented as means (±SD) of three independent repeats in triplicate cells. NB, addition of sodium azide to cells 
did not result in any cell death compared to controls.
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The membrane damaging effect of these peptides was also assessed with P. aeruginosa 6294 by the flow 
cytometry in the presence of the DNA intercalating dye Propidium Iodide, which is only permeable to cells with 
damaged membranes, and Syto 9 which can enter intact cells. The peptides were able to permeabilize the cell 
membrane in a concentration independent manner, but this effect was time-dependent, and similarly to experi-
ments with Sytox green, maximum permeabilization occurred after 150 mins incubation (Fig. 3). For melimine at 
its MIC, after 30 mins exposure 10% of cells were not stained, 15.2% were stained with only Syto 9, 74.8% showed 
membrane permeabilization (22.3% of cells were doubled stained, 52.5% were stained only with Propidium 
Iodide). After 150 minutes of exposure, 97.5% of the cells had permeabilized membranes (7.8% double stained, 
89.7% stained with only Propidium Iodide). Although Mel4 permeabilized P. aeruginosa membranes, permeabi-
lization and the kinetics was different compared with melimine. After 30 min exposure to Mel4 at its MIC 5.2% 
of cells were not stained, 64.7% were stained with only Syto 9, and 30.1% of cells had permeabilized membranes 
(12.4% double stained, 17.7% cells stained only with Propidium Iodide). After 150 minutes exposure, 1.2% of cells 
were not stained, 26.4% were stained with Syto 9 only, and 72.3% of cells had permeabilized membranes (25.6% 
doubled stained, 46.7% stained only with Propidium Iodide; Fig. 3). The positive control Triton-X 100 showed 
different kinetics to both peptides. After 30 minutes exposure 46.1% of cells were not stained, 27.7% were stained 
with only Syto 9, 7.6% were double stained and 18.7% were stained with only Propidium Iodide. After 150 min 
exposure, 60% of cells were unstained, 3.1% were stained only with Syto 9, 2.4% were doubled stained and 34.1% 
were stained with only Propidium Iodide. The negative control (buffer-treated) behaved as expected and <7% 
permeabilized (Fig. 3).
The release of cytoplasmic contents. Melimine released 75% and 92% of total cellular ATP at 1x and 2x 
its MIC after 2 minutes (P < 0.001) (Fig. 4). The increase of extracellular ATP directly correlated with the loss of 
viability of P. aeruginosa (R2 > 0.987). Within the first two minutes, melimine decreased viability by >3.0 log10. 
Exposure to Mel4 released 36% and 44% extracellular ATP at 1x or 2x its MIC after 2 minutes (Fig. 4). Further 
incubation for 10 minutes resulted in a slight increase in the release of extracellular ATP. The release of ATP was 
associated with the reduction of >2.0 log10 viable bacteria. Melimine induced more leakage of ATP than Mel4 
(P < 0.001).
Figure 5 shows the releases of DNA/RNA (260 nm absorbing material) following incubation with the pep-
tides. The release of DNA/RNA of P. aeruginosa was significantly (P < 0.001) increased compared to the negative 
control after 2 minutes incubation with either peptide. Melimine was associated with a dose-dependent release 
of DNA/RNA but the release of DNA/RNA was not affected by the concentration of Mel4. Compared with Mel4, 
melimine released higher amounts of DNA/RNA at all time points (P < 0.001).
Bacterial lysis. When the lower cell concentration of cells (1 × 108 CFU/ml) was used, no decrease in 
OD620 nm could be seen as the optical density was very low to start with. When 1 × 1010 CFU/ml was used and 
treated with varying concentrations significant reductions in OD620 nm was observed (Fig. 6). After incubation 
with melimine for 2 hours, the OD620 nm was significantly reduced by 25 ± 12% at 1x MIC and 31 ± 3% at 2x MIC 
compared to at time zero (P < 0.001). OD620 nm was further reduced by 37 ± 03% and 52 ± 10% with 1x and 2x 
MIC after 6.5 hours respectively. After 24 hours incubation melimine had lysed >55 ± 5% of cells at both concen-
trations. A similar trend was seen for Mel4 which reduced the OD620 nm by 13 ± 8% and 21 ± 6% at 1x and 2x MIC 
respectively after 2 hours (P ≤ 0.015). Further reductions in OD620 nm by 20 ± 3% with 1x and 48 ± 5% with 2x 
MIC was observed after 6.5 h. Similarly, OD620 nm decreased by 52 ± 2% by both the concentrations of Mel4 after 
24 hours of incubation (P < 0.004) (Fig. 6). The bacteriolytic efficiency of both melimine and Mel4 was similar at 
their MICs (P = 0.927) and 2x MICs (P > 0.999) but 2x MIC of melimine caused more lysis than 1x MIC of Mel4 
(P < 0.004) after 24 hours of incubation. The OD620 nm of cells in the absence of peptides remained unchanged over 
the 24 hours of the experiment.
Figure 2. Cytoplasmic membrane permeability of P. aeruginosa 6294 by melimine and Mel4 at different 
concentrations. Fluorescence due to binding of Sytox green fluorescent probe with DNA was measured 
spectroscopically at 480 nm to 522 nm excitation and emission wavelength. Data presented as means (±SD) of 
three independent repeats in triplicate.
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Figure 3. Membrane permeabilization of P. aeruginosa 6294 produced by melimine and Mel4 at their 
MICs determined by flow cytometry with Syto 9 (membrane permeable) and Propidium Iodide (membrane 
impermeable) stains.
Figure 4. The effect of melimine and Mel4 on ATP release from P. aeruginosa 6294 at MIC and two times 
MIC and the corresponding change in the number of viable cells. Data presented as means (±SD) of three 
independent repeats in triplicate compared with buffer-treated control.
Figure 5. Increase of DNA/RNA from P. aeruginosa 6294 due to action of melimine and Mel4 at MIC and two 
times MIC determined spectroscopically at OD260 nm. Data presented as means (±SD) of three independent 
repeats in triplicate compared with buffer-treated control.
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Discussion
Over last decade, melimine and Mel4 have been extensively studied in vitro, and in animal models and human 
clinical trials. This study for the first time compared and contrasted the timeline of the antimicrobial mechanism 
of actions of these two cationic peptides. The effects of either peptide on all the strains of P. aeruginosa was similar. 
Both peptides were able to significantly neutralise the endotoxic activity of LPS. Both peptides could depolarize 
the cytoplasmic membrane, and this was associated with rapid loss of cell viability. Loss of viability occurred more 
rapidly with melimine than Mel4. Cytoplasmic membrane depolarization was followed by ATP and DNA/RNA 
release from cells and permeabilization of the membrane. When incubated with peptides for 24 hours 50–60% of 
cells were lysed.
Usually the LAL assay generally does not reveal specific mechanism of interaction of AMPs with LPS com-
ponents. However, there are number of studies which have used the LAL assay to study the interaction and 
hypothesized the possible way of AMPs interaction with individual components of LPS. The neutralization of 
LAL activity has been used previously to study the interaction of AMPs LL-37, LF-33 and HNPs-1–4 with the 
LPS33,34. The LAL assay is believed to be neutralized due to the binding of peptides to the lipid A portion of endo-
toxin34. The lipid A portion of endotoxin is responsible for the activation of LAL35,36. More specifically, using the 
lipopeptides LF12 and polymyxin B it has been suggested that the interaction between peptides and LPS may 
be due to binding of the cationic peptides to phosphate groups on the LPS and lipid A portion37. Furthermore, 
hydrophobic interactions between the acyl chain of the lipopeptides and the lipid chains of LPS may also occur37. 
Mel4 has no hydrophobic residues, and melimine is only very weakly hydrophobic (Table 3) (Fig. 7), Mel4 and 
melimine probably interact with LPS predominantly through the phosphate groups on lipid A. Melimine killed 
more cells compared to Mel4 at each timepoint. This may be due to their different sizes and structure. The amino 
acid length required for peptides to span bacterial cytoplasmic membranes is approximately 15–20 residues38–40. 
Mel4 is composed of 17 amino acids, just within the membrane spanning length, whereas melimine has 29 amino 
acid which probably allows it to easily span the cytoplasmic membrane of P. aeruginosa. The shorter length of the 
Mel4 peptide may mean that it takes longer to penetrate through the outer membrane or start to interact with the 
inner membrane of P. aeruginosa in order to kill the bacteria, or it needs to orientate itself more effectively into 
the membrane to begin to exert its affects. Also, tryptophan (Trp) in melimine’s amino acid sequence which is 
not in Mel4 may have effects. Trp is known to interface with lipid bilayers and can enhance peptide-membrane 
interactions and facilitate peptide insertion into membranes29,41. A helical peptide RW-BP100 possess a Trp res-
idue which confers higher affinity and deeper insertion into bacterial membranes42. In addition, Trp facilitates 
the insertion of arginine, which is in high mounts in melimine, into the hydrophobic region of membranes via 
cation–π interactions causing rapid membrane disruption29. Melimine, partly due to the presence of Trp, adopts 
a partial α helix in bio-membrane mimetic environments23. A higher helical conformation of peptides is better 
suited for their antimicrobial activity43. As Mel4 lacks tryptophan in its sequence, it may have less affinity towards 
phospholipid bilayers44. Furthermore, the amino acid sequence of Mel4 predicts that it would have a very low 
hydrophobic moment (0.039; Table 3) meaning that it is less likely to be attracted within lipid bilayers45,46. Also, 
helical wheel projections of melimine and Mel4 show that the hydrophobic amino acids in melimine segregate 
to one side of the molecule, whereas as there are no hydrophobic amino acids in Mel4 that can segregate (Fig. 7). 
The presence of non-polar amino acids such as Ile and Leu can encourage peptide binding and disruption of 
cell membranes32 and their absence in Mel4 compared to melimine may also affect the initial mode of action of 
Mel4. Compared to melimine, Mel4 has been shown to be unable to interact with lipid spheroids composed of 
1-oleoyl-2hydroxy-sn-glycero-3-phosphocholine (PC 18:1) or tethered lipid bilayers composed of 70% zwitteri-
onic C20 diphytanyl-glycero-phosphatidylcholine lipid and 30% C20 diphytanyldiglyceride ether44. The evidence 
from the current study suggests that it takes more time for Mel4 to interact with the bacterial membranes to the 
same extent as melimine which may be due to the changes in its amino acid sequence and subsequent changes 
in its structure. Indeed, for lipid depolarisation at their respective MICs, it took Mel4 approximately 30 seconds 
longer to achieve the same degree of depolarisation and 60 seconds longer to achieve the same degree of killing 
compared to melimine (Fig. 1A,B). To permeabilize the cytoplasmic membrane to allow Sytox green to enter cells, 
Figure 6. Lysis of P. aeruginosa 6294 by melimine and Mel4 at MIC and two times MIC measured 
spectroscopically at OD620 nm. Data presented as means (±SD) of three independent repeats in triplicate 
compared with buffer-treated control.
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Mel4 at its MIC took more than 30 minutes to achieve the same degree of permeabilization that melimine did at 
its MIC at 5 min. Confirmation of the role of Try, Ile or Leu in the action of Mel4 needs to be confirmed in future 
studies that incorporate one or more of these amino acids in Mel4.
The membrane depolarization caused by both melimine and Mel4 was a concentration dependent event. 
These results are in agreement with previous studies showing a concentration-dependent depolarizing effect of 
the helical peptide LL-37 on P. aeruginosa, and PMAP-36, GI24 and melittin on E. coli cell membranes47,48. To fur-
ther confirm whether membrane depolarization was a lethal event for these peptides, viable count was performed. 
Both AMPs reduced bacterial numbers upon membrane depolarization. Higher concentration of AMPs resulted 
in higher degrees of depolarization which in turn led to larger amounts of bacterial death. Interestingly, sodium 
azide depolarization of the cell membrane did not affect cell viability. This suggest that membrane depolarization 
by itself was not sufficient to cause death of P. aeruginosa.
The membrane potential is essential for bacterial replication and ATP generation49. Dissipation of the mem-
brane potential may increase membrane permeability resulting in loss of cytoplasmic contents such as ATP50. 
In the present study more than 70% of total cellular ATP was released by melimine and approximately 35% by 
Mel4 following 2 minutes exposure, and the amount of ATP released plateaued after 4 minutes exposure to both 
peptides. The effect of melimine is similar to porcine cathelicidin’s PR-39 effect on E. coli which induced 80% ATP 
leakage51. The leakage of ATP results in depletion of intracellular ATP which in turn can lead to bacterial death52. 
Interestingly, over the course of the study (10 mins), the amount of ATP released from cells during exposure to 
Mel4 never reached the amount released following exposure to melimine and also appeared to plateau indicating 
saturation. ATP released by bacteria can be depleted in supernatants of cells, possibly by hydrolysis at their cell 
surfaces52. The data from the current experiments may indicate that cells treated with Mel4 retain some capacity 
to degrade extracellular ATP.
The permeability of cytoplasmic membrane also resulted in Sytox green uptake into cells. However, this uptake 
was relatively slow, and did not reach the level obtained with the positive control Triton X-100. Indeed, after 
30 minutes incubation the amount of fluorescence due to Sytox green entering cells was equivalent to the amount 
that had entered cells after 10 minutes exposure to Triton X-100 when incubated with melimine, and <150 min-
utes when incubated with Mel4. Furthermore, with either melimine or Mel4 it took approximately 5 minutes for 
any fluorescence due to Sytox green to be registered. The difference in the time between membrane depolariza-
tion and Sytox green entering cells may be due to Sytox green requiring relatively large pore sizes in bacterial cell 
membranes for its uptake and time to intercalate with DNA. Compared with Sytox green uptake, ATP release was 
faster, and this may be due to the different mechanisms of entry/exit through cellular membrane. For example, the 
pore size needed for ATP to penetrate through membranes is a pore size of 1.5 nm53, which may be smaller than 
that needed for Sytox green to enter into cells. It may also take a longer time of Sytox green to cross the bacterial 
membranes and intercalate with DNA54,55. The differences in the apparent rate of ATP release compared to Sytox 
green entry into cells may also be due to differences in the assay sensitivities. Similar kinetics to the current study 
of Sytox green staining resulting from interactions of the AMPs melittin (a parent peptide of melimine and Mel4) 
and LL-37 has been reported against other Gram-negative bacteria such as P. aeruginosa, E. coli and Salmonella 
typhimurium56.
To further assess whether the peptides could damage the bacterial cell membrane, Propidium Iodide stain 
was used as an indicator of cells with ruptured membranes. Flow cytometry analysis indicated that treatment 
of P. aeruginosa with the both AMPs enhanced uptake of PI, suggesting that the bacterial cell membrane 
was disrupted. More than 50% cells stained with PI after exposure to melimine for 30 minutes at its MIC. 
However, Mel4 took longer (150 min) for a similar amount of the cells to stain with PI at its MIC (Fig. 3). The 
Figure 7. Helical wheel projection of melimine and Mel4. Positive charged residues are represented in blue 
circles, uncharged residues are in grey circles, polar residues in pink circles and hydrophobic residues in yellow 
circles.
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positive control Triton-X resulted in less PI positive cells at this time point suggesting different rates of mem-
brane permeabilization. Therefore, the sequence of steps occurring at the membrane, appears to begin with 
depolarization and followed by more significant membrane disruption (Sytox green and Propidium Iodide) 
influx which occur approximately at the same time as ATP and initial DNA/RNA leakage. The apparent dif-
ferences in kinetics of Triton X100 with Sytox green and Propidium Iodide may be due to differences in types 
of pores that need to be formed to allow penetration of the two dyes into the bacteria, or interactions of the 
dyes with Triton X100.
Melimine caused a concentration-dependent release of DNA/RNA (260 nm absorbing material) as 
early as in 2 minutes, which is consistent with the results obtained by Minahk et al.57 who demonstrated a 
concentration-dependent release of DNA/RNA from Listeria monocytogenes after treatment with the anti-
microbial peptide Enterocin CRL35 at the concentrations equal to its MIC and >4x its MIC. However, Mel4 
induced release of DNA/RNA was dose independent. The dose independence of the Mel4 release of DNA/
RNA may possibly have occurred due to aggregation of Mel4. However, we have shown that a variant of Mel4 
containing a cysteine residue at its N-terminus (cys-mel4) does not dimerise in solution44 and this would be 
even more likely that Mel4 to dimerise given that cysteine residues can form disulphide bonds. Furthermore, 
we have previously shown that Mel4’s parent analogue melimine does not aggregate in PBS or distilled water 
using AFM. The high positive charges of melimine and Mel4 would mean dimerization is not electrostati-
cally favourable. There was also a stepped release of DNA/RNA, with an initial burst release 2 minutes after 
addition of melimine or Mel4, and then another release of DNA/RNA between 60–150 minutes after addi-
tion of the peptides. The amount of DNA/RNA release caused by Mel4 did not reach the level released after 
exposure to melimine even at longer incubation times. AMPs have been shown to permeabilize bacterial 
membranes by forming morphologically diverse pores in terms of diameter, lipid conformation surrounding 
the pores, life span and threshold of AMPs require to stabilize the pores58, and perhaps melimine and Mel4 
form morphologically diverse pores which affect release of large molecules such as DNA/RNA. The two-step 
process of DNA/RNA release may be due to damage and disintegration of DNA/RNA within the cell over 
the 150 minutes incubation with the peptides allowing smaller lengths of DNA to exit cells. This may occur 
during so-called bacterial apoptosis-like death, mediated via recA, such as occurs during antibiotic-induced 
bacterial death59. Examining changes in recA and the size of the liberated DNA/RNA in future experiments 
may help understand this further. Eventually, both peptides result in complete cellular lysis of P. aerugi-
nosa. Furthermore, whilst there were some differences in the MIC and MBC between strains, both peptides 
behaved in a similar manner to all four strains of P. aeruginosa (see Supplementary Data), indicating that 
there were no differences in the interaction whether the strains were of the invasive or cytotoxic genotype or 
phenotype, and the only effect of MIC or MBC differences were to the amount of peptides that were needed 
to kill cells, not to their mechanism of action.
In conclusion this study has revealed a comprehensive timeline of the mode of actions of melimine and Mel4 
against P. aeruginosa which involves disruption of the cell membranes, efflux of its intracellular contents and lysis 
of bacteria. Figure 8 summarizes the sequence of events that occurs after incubation of P. aeruginosa cells with 
either peptide over 2 hours. It is likely that the amphipathic characteristics of melimine allowed disruption of the 
cell membrane more rapidly than Mel4 which only had very low amphipathicity.
Materials and Methods
All experiments were run in triplicate and repeated on three separate occasions, except for flow cytometry data 
which were obtained after two repeats. For all experiments, negative controls for the effect of melimine and Mel4 
were simply bacterial cells grown in their absence.
Synthesis of peptides. Melimine and Mel4 (≥90% purity) used in the current study were synthesized by 
conventional solid-phase peptide protocols60,61 and procured from the Auspep Peptide Company (Tullamarine, 
Victoria, Australia).
Bacterial strains. Different strains of P. aeruginosa such as 6294 and 6206 (microbial keratitis isolates; 6294 
an invasive strain containing the exoS gene and 6206 a cytotoxic strain containing the exoU gene62), Paer1 (iso-
lated from contact lens induced acute red eye, contains the exoS gene but does not manifest the associated inva-
sive phenotype62) and ATCC 19660 (isolated from human septicaemia; a cytotoxic strain containing the exoU 
gene63) were used in the current study. All these strains were obtained from stock cultures preserved at −80 °C in 
Brain Heart Infusion (Oxoid, Basingstoke, UK) containing 25% glycerol.
Bacterial cell preparation. Bacteria were grown in Tryptic Soy Broth (TSB; Oxoid) for 12–16 h and cells 
were then washed with phosphate buffer saline (PBS, NaCl 8 g/L, KCl 0.2 g/L, Na2HPO4 1.4 g/L, KH2PO4 0.24 g/L) 
and diluted into the same buffer containing 1/1000 TSB to OD600 nm 0.05–0.06 (1 × 107 colony forming units 
(CFU)/ml confirmed upon retrospective plate counts on TS agar (Oxoid). This inoculum preparation was used in 
most experiments except for assessing the minimum inhibitory and bactericidal concentrations which used cells 
in Muller Hinton broth and measuring the release of DiSC3–5 from cells which was performed in cells (1 × 107 
CFU/ml) suspended in HEPES buffer.
Minimum inhibitory and bactericidal concentrations. The minimum inhibitory and minimum bac-
tericidal concentrations of melimine and Mel4 were determined for all strains using a modified version of the 
Clinical Laboratory and Standard Institute (CLSI) broth microdilution method as reported previously64, using 
Muller Hinton Broth (Oxoid) containing 0.01% v/v acetic acid (Sigma Aldrich, St Louis, MO, USA) and 0.2% 
w/v bovine serum albumin (Sigma Aldrich; MHB). Bacterial cells, diluted to 5 × 105 CFU ml−1 in MHB, were 
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incubated with various concentrations of the peptides. The MIC was set as the lowest concentration of peptides 
that reduced bacterial numbers by ≥90% while the MBC was set as the lowest concentration of peptides that 
reduced bacterial growth by >99.99% after enumeration of viable bacteria by plate count method compared to 
bacteria grown with no antimicrobial agent.
Interaction with P. aeruginosa lipopolysaccharide. A limulus amoebocyte lysate (LAL) assay was per-
formed to determine the interaction of AMPs with lipopolysaccharides (LPS) of P. aeruginosa using a chromo-
genic assay kit (Cape Cod, E. Falmouth, MA, USA). Briefly, 8 × 10−4 nmol/ml LPS from P. aeruginosa 10 (Sigma 
Aldrich, St Louis, MO, USA) was dissolved with melimine and Mel4 at 1x or 2x MIC in endotoxin free water 
(Sigma Aldrich, St Louis, MO, USA) and incubated at 37 °C for 30 minutes. The interaction of LPS with melimine 
or Mel4 was assessed as the decrease in OD405 nm following addition of the LAL reagent, compared with control 
(LPS in endotoxin free water) without peptides in (percentage) using the formula.
−
×
(OD of Positive Control) (OD of Samples)
(OD of Positive Control)
100405 nm 405 nm
405 nm
Cytoplasmic membrane disruption. Three assays were performed to determine whether melimine and 
Mel4 could affect the cytoplasmic membrane of P. aeruginosa. The DiSC3-5 assay was used to determine the effect 
of the peptides on membrane potential. Two assays, Sytox Green and Propidium Iodide, were conducted to deter-
mine whether the peptides could damage cytoplasmic membranes and allow the stains to penetrate and bind to 
intracellular nucleic acids. Sytox Green has a molecular mass of 215.025 g/mol and a topological polar surface area 
of 28.7 A2 (https://pubchem.ncbi.nlm.nih.gov/compound/46863923)65, whereas Propidium Iodide has a molec-
ular mass of 668.087 g/mol and a topological polar surface area of 55.9 A2 (https://pubchem.ncbi.nlm.nih.gov/
compound/104981)66. Differences in the penetration of these two dyes through the cytoplasmic membranes may 
be associated with different sizes of pores formed by the AMPs.
Cytoplasmic membrane depolarization by the AMPs was performed as described previously23 with melimine 
and Mel4 at 1x and 2x MIC at the final concentrations. The number of viable cells were confirmed by serially 
diluting aliquots of bacteria in D/E neutralizing broth (Remel, Lenexa, KS, USA) and plating these onto Tryptic 
Soy Agar (Oxoid, Basingstoke, UK) containing phosphatidylcholine (0.7 g/L) and Tween 80 (5 ml/L). The plates 
were incubated at 37 °C overnight and the number of live bacteria were enumerated and expressed as CFU/ml. 
Two positive controls of dimethyl sulfoxide (DMSO) (Merck, Billerica, MA, USA) (20% v/v) in HEPES (100 µl) 
and sodium azide were used to depolarize the cytoplasmic membranes of bacteria67.
For Sytox green penetration into cells, the protocol was adopted from Li et al.58 with a few modifications. 
Briefly, bacterial cells, aliquots (100 µl) were dispensed into wells of 96-well plates along with 5 µM Sytox green 
(Invitrogen, Eugene, Oregon, USA) as final concentrations. Plates were incubated for 15 minutes in the dark at 
room temperature and then 100 µl of melimine and Mel4 were added equal to 1x or 2x as final concentrations. 
The increase in fluorescence was measured spectrophotometrically (at an excitation wavelength of 480 nm and an 
emission wavelength of 522 nm) every 1 minutes up to 30 minutes, and then after 150 minutes. A positive control 
of 1% (v/v) Triton X-100 (Sigma Aldrich, St Louis, MO, USA) in PBS with 1/1000 TSB (100 µl) was used to disrupt 
the cytoplasmic membrane of bacteria.
Flow cytometry was used to quantify the ability of melimine and Mel4 to permeabilize bacterial membranes 
of P. aeruginosa 6294 resulting in incorporation of propidium iodide (PI) (Invitrogen, Eugene, Oregon, USA) 
into cells with compromised cell membrane. Bacterial cells were stained simultaneously with SYTO9 and PI at 
concentrations of 7.5 µM and 30 µM respectively and incubated at room temperature for 15 min. Fluorescence 
intensities were recorded with LSRFortessa SORP Flow cytometer after addition of 1x and 2x MIC of melimine or 
Mel4 at different time points. The wavelength of green fluorescence was (525/550 nm) bandpass filter for SYTO9 
Figure 8. Timeline of P. aeruginosa killing by melimine and Mel4. Both AMPs started cell membrane 
depolarization at 30 seconds. Cell membrane permeabilization, release of ATP and DNA/RNA happened 
between 2 to 5 minutes of exposure. Complete bacterial lysis started at 120 minutes of incubation with peptides. 
All the events started at same time point for both AMPs but intensity of event to occur for melimine was higher 
than Mel4 at each studied time point.
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and a red fluorescence (610/20 nm) bandpass filter for PI68. Data were acquired and analyzed using Flowjo soft-
ware (USA). Minimum 20000 events were recorded for each sample.
Leakage of intracellular contents. The leakage of ATP and DNA/RNA was measured in separate assays. 
Aliquots of 100 µl of bacteria were incubated with melimine at the final concentrations equal to 1x or 2x MIC and 
at 37 °C for 10 minutes. The samples were taken at 2 min intervals and centrifuged at 9000 × g for 5 minutes and 
the supernatant was kept on ice until further use. For determination of internal ATP the bacterial pellets were 
resuspended in boiling 100 mM Tris, 4 mM EDTA pH (7.4) and further incubated for 2 mins at 100 °C to lyse all 
the cells. The lysed cells were centrifuged at 9600 × g for two minutes and the supernatant was kept on ice until 
further analysis51. Subsequently, both total and extracellular ATP were determined using an ATP biolumines-
cence kit (Invitrogen, Eugene, Oregon, USA) according to manufacturer’s instructions.
The assay for measuring the loss of DNA/RNA was performed according to protocol Carson et al.69 with some 
modification. Aliquotes (100 µl) of bacteria was mixed with melimine and Mel4 at their 1x or 2x MIC and incu-
bated at 37 °C. Samples were collected at different time intervals, diluted (1:10) and filtered through 0.22 µm pores 
(Merck, Tullagreen, Ireland). The OD260 nm of the filtrates was measured in UV-star plate (Greiner Bio-one GmbH, 
Frickenhausen, Germany). The results were expressed as the ratio to the initial OD260 nm.
Lysis of bacteria. This experiment was adopted from the method of Carson et al.69. The bacterial lytic 
potential of the two peptides was evaluated using two different bacterial inoculums 1 × 108 CFU/ml and 3 × 1010 
CFU/ml. The smaller inoculum size was tested to see whether OD620 nm was measurable for 1 × 108 CFU/ml. The 
OD660 nm of bacterial suspension was adjusted to 0.1 to yield 1 × 108 CFU/ml. The larger inoculum size of 3 × 1010 
CFU/ml was obtained by adjusting OD620 nm 0.3. The bacterial numbers CFU/ml were confirmed by retrospective 
plate count. Melimine and Mel4 were added at 1x MIC and 2x MIC as final concentrations. Bacterial cultures were 
immediately mixed and then diluted 1:1000 in TSB. The initial OD620 nm was measured and additional readings 
were taken at 30, 60, 90, 120 minutes, 6.5 and 24 h after incubating at room temperature. PBS with peptides at 
their respective concentrations was used as blank. The results were recorded as a ratio of OD620 nm at each time 
point compared to the OD620 nm at 0 minutes (in percentage).
Statistical analyses. Statistical analyses were performed using GraphPad Prism 7.02 software (GraphPad 
Software, La Jolla, CA, USA). Neutralization of LPS was estimated using one-way ANOVA with Tukey’s test. The 
time dependent effect of different concentrations of peptides was analysed using two-way ANOVA with Tukey’s 
test of multiple comparisons. Correlations between release of extracellular ATP and bacterial death were exam-
ined using Pearson correlation test. Statistical significance was set as P < 0.05.
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